Coventry Observer A country-wide first for University Hospitals Coventry and Warwickshire in fight to tackle Crohn’s disease (1 Viewer)

[Newsbot]

The INTREPID study will see those with the condition trial the impact of the new brazikumab drug.

Continue reading...